Cornercap Investment Counsel Inc Iovance Biotherapeutics, Inc. Transaction History

Cornercap Investment Counsel Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$7.78 - $14.19 $2,310 - $4,214	-297 Reduced 0.94%	31,360 $251,000
Q4 2023 Jan 30, 2024	SELL	$3.3 - $8.89 $188 - $506	-57 Reduced 0.18%	31,657 $257,000
Q3 2023 Nov 13, 2023	SELL	$4.44 - $8.79 $1,998 - $3,955	-450 Reduced 1.4%	31,714 $144,000
Q2 2023 Aug 11, 2023	SELL	$5.36 - $9.06 $29,581 - $50,002	-5,519 Reduced 14.65%	32,164 $226,000
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $111,978 - $199,250	19,925 Added 112.2%	37,683 $240,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $58,561 - $80,560	6,145 Added 52.91%	17,758 $170,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $74,090 - $212,866	11,613 New	11,613 $128,000

320

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $958M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.